Cooper Companies (NASDAQ:COO) Updates FY 2026 Earnings Guidance

by · The Cerbat Gem

Cooper Companies (NASDAQ:COO – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.450-4.600 for the period, compared to the consensus estimate of 4.390. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $4.3 billion. Cooper Companies also updated its Q1 2026 guidance to 1.020-1.040 EPS.

Cooper Companies Price Performance

Shares of COO stock traded up $1.05 during mid-day trading on Thursday, hitting $77.03. 5,109,095 shares of the stock traded hands, compared to its average volume of 2,409,264. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $104.47. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The company’s 50-day simple moving average is $71.81 and its 200-day simple moving average is $71.70. The firm has a market cap of $15.31 billion, a price-to-earnings ratio of 37.95, a price-to-earnings-growth ratio of 1.90 and a beta of 1.05.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities research analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Cooper Companies declared that its board has authorized a stock buyback plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to buy up to 15.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a report on Thursday, August 28th. Needham & Company LLC restated a “buy” rating and issued a $94.00 price target on shares of Cooper Companies in a research report on Thursday, August 28th. Barclays started coverage on Cooper Companies in a report on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target on the stock. The Goldman Sachs Group set a $64.00 price objective on Cooper Companies and gave the stock a “sell” rating in a research note on Wednesday, October 1st. Finally, Stifel Nicolaus decreased their target price on Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $84.77.

Read Our Latest Stock Analysis on Cooper Companies

Insiders Place Their Bets

In related news, CEO Albert G. White III purchased 10,000 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were bought at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Gerard H. Warner III acquired 1,450 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were bought at an average cost of $69.23 per share, with a total value of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares of the company’s stock, valued at $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 13,450 shares of company stock worth $921,064 in the last ninety days. Insiders own 1.98% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

Several large investors have recently modified their holdings of the stock. Cresset Asset Management LLC increased its stake in shares of Cooper Companies by 7.5% in the third quarter. Cresset Asset Management LLC now owns 4,393 shares of the medical device company’s stock valued at $301,000 after buying an additional 306 shares in the last quarter. Captrust Financial Advisors grew its holdings in Cooper Companies by 10.0% during the 2nd quarter. Captrust Financial Advisors now owns 3,500 shares of the medical device company’s stock worth $249,000 after acquiring an additional 317 shares during the last quarter. Snowden Capital Advisors LLC increased its position in Cooper Companies by 10.0% in the 2nd quarter. Snowden Capital Advisors LLC now owns 4,088 shares of the medical device company’s stock valued at $291,000 after acquiring an additional 373 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in Cooper Companies by 0.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 62,229 shares of the medical device company’s stock valued at $4,266,000 after acquiring an additional 386 shares in the last quarter. Finally, Siemens Fonds Invest GmbH raised its stake in shares of Cooper Companies by 22.0% in the third quarter. Siemens Fonds Invest GmbH now owns 2,782 shares of the medical device company’s stock worth $191,000 after acquiring an additional 502 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More